Back
OncoCyte Stock Price Chart
Sponsored
OCX
Sponsored
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
27
OCX
OncoCyte
Last Price:
3.00
Seasonality Move:
-0.82%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing selling pressure, which indicates risk of future bearish movement.
OncoCyte Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.11 | Sell |
20-day SMA: | 3.11 | Sell |
50-day SMA: | 3.13 | Sell |
200-day SMA: | 2.98 | Sell |
8-day EMA: | 3.08 | Sell |
20-day EMA: | 3.1 | Sell |
50-day EMA: | 3.07 | Sell |
200-day EMA: | 3.35 | Sell |
OncoCyte Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 41.95 | Sell |
Chaikin Money Flow: | -6069 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.03 - 3.17) | Sell |
Bollinger Bands (100): | (2.74 - 3.18) | Sell |
OncoCyte Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for OncoCyte Stock
Is OncoCyte Stock a Buy?
- OncoCyte share price is 2.95 while OCX 8-day simple moving average is 3.11, which is a Sell signal.
- The stock price of OCX is 2.95 while OncoCyte 20-day SMA is 3.11, which makes it a Sell.
- OncoCyte 50-day simple moving average is 3.13 while OCX share price is 2.95, making it a Sell technically.
- OCX stock price is 2.95 and OncoCyte 200-day simple moving average is 2.98, creating a Sell signal.
OCX Technical Analysis vs Fundamental Analysis
OncoCyte Stock Info
Market Cap:
39.44M
Price in USD:
2.95
Share Volume:
6.07K
OncoCyte 52-Week Range
52-Week High:
4.34
52-Week Low:
2.08
Sell
27
OncoCyte (OCX)
is a Sell
OncoCyte Share Price Forecast
-
What is the OncoCyte stock price today?
The OncoCyte stock price is 2.95 USD today. -
Will OCX stock go up or go down?
OncoCyte> share price is forecast to RISE/FALL based on technical indicators -
Is OncoCyte overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, OncoCyte is overvalued.
Is OncoCyte Stock a Buy?
- OncoCyte share price is 2.95 while OCX 8-day exponential moving average is 3.08, which is a Sell signal.
- The stock price of OCX is 2.95 while OncoCyte 20-day EMA is 3.10, which makes it a Sell.
- OncoCyte 50-day exponential moving average is 3.07 while OCX share price is 2.95, making it a Sell technically.
- OCX stock price is 2.95 and OncoCyte 200-day simple moving average is 3.35, creating a Sell signal.
Fundamental Analysis of OncoCyte
Is OncoCyte a good investment?
- Analysts estimate an earnings decrease this quarter of $0.41 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
Technical Analysis of OncoCyte
Should I short OncoCyte stock?
- OCX Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting OncoCyte is a Sell
- OncoCyte Relative Strength Index (RSI) is 41.95, which suggest OncoCyte is oversold
- The Bollinger Bands (25) for OncoCyte is (3.03 - 3.17), which suggest OncoCyte is a Sell
- The Bollinger Bands (100) for OncoCyte is (2.74 - 3.18), which suggest OncoCyte is a Sell
* OncoCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.